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Effects of Cinnamon Consumption on Glycemic Status, Lipid Profile and Body 
Composition in Type 2 Diabetic Patients
Rajadurai Akilen
DEAR EDITOR
With curiosity we read the original article by 
Vafa et al.[1] They examined the effects of  the daily 
intake of  3 g cinnamon on glycemic status, lipid 
profiles and body composition in Iranian type 
2 diabetic patients, and concluded that cinnamon 
may have a moderate effect in improving 
glycemic status indicators. The results of  this 
study certainly gave some novel expectation for 
efficacy of  cinnamon on glycaemic control. Recent 
meta‑analysis also demonstrated that cinnamon 
improves fasting blood glucose (FBG) and glycated 
haemoglobin A1c (HbA1c) in diabetic patients.[2,3] 
The author is to be congratulated for conducting 
such a comprehensive study on a topic of  high 
importance both for healthcare providers and 
researchers. Here we provide comments on three 
points;
First; it seems that there is a significant difference 
in baseline fasting blood glucose and triglyceride 
levels between groups in this study [Table 1], which 
could potentially affect the results of  this study. 
A common practice in randomized parallel group 
clinical trials is to perform tests of  homogeneity on 
covariates measured at or before randomization. 
Another concern that arises from this study is that, 
patients had very high mean serum triglycerides, 
total and low density lipid (LDL) cholesterol 
levels at baseline in both groups, and we wonder 
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whether any of  these patients were treated with 
cholesterol lowering medications. Why a potential 
recommendation was not made for patients with 
elevated serum triglycerides and LDL cholesterol, 
if  the patients were not using any cholesterol 
lowering medication.
Second; we would like the authors to elucidate 
us on some of  the following methodological 
matters, which could possibly interrupt the 
significance of  results. Since a dropout did occur 
in this study (n  =  7), we wonder whether intend 
to treat (ITT) analysis could be performed in 
this study. Although discussion of  ITT analysis 
might be beyond the scope of  this study, many 
researchers considered ITT to be the preferred 
method of  data analysis in clinical trials, as it is 
less prone to bias. Furthermore, we are also eager 
to know the contents of  3 g placebo capsules and 
how the matching strong smell of  cinnamon used 
in placebo capsules for double blinding.
Table 1: Baseline characteristics of the study population
Variables Cinnamon  
(n=19)
Placebo  
(n=18)
Triglycerides (mg/dl) 163.32 + 52.66 135.67 + 40.52
Total Cholesterol (mg/dl) 169.37 + 32.69 155.44 + 35.33
Fasting Plasma 
Glucose (mg/dl)
149.28 + 9.11 136.911 + 9.11
Data presented as mean ± SD, obtained from Vafa et al.[1]
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Third; another concern that arises from this study 
is the use of  3 g of  cinnamon dose. According to the 
results of  our previous review and meta‑analysis,[2,4] 
this is the first study which showed a significant 
reduction in HbA1c and FBG due to higher dose 
of  cinnamon supplementation (3 g of  cinnamon), 
and we would also like to know whether patients 
in this group showed any intolerance or side effects 
due to higher cinnamon dosage.
Finally, as HbA1c remains the most important 
long‑term predictor of  complications in both type 1 
and type 2 diabetes, the effect of  any intervention 
on glycated haemoglobin A1c (HbA1c) is critical 
in determining its clinical usefulness. In this study, 
participants were not given cinnamon for a long 
enough duration of  more than 12 weeks. Because 
8 weeks of  study duration is less than the full 
120‑day lifespan of  red blood cells, perhaps this 
shorter duration contributed to a false‑negative 
result of  HbA1c in this study, and we would like to 
know the authors opinion on this.
In conclusion, this study certainly added 
evidence to the existing literature, and demonstrated 
a beneficial effect of  short term (8 weeks) 
consumption of  cinnamon on glycaemic control. 
Obviously, large scale clinical trials are needed 
to confirm the long‑term tolerability, safety, and 
efficacy of  cinnamon on glycaemic indicators.
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